3-hydroxyphthalic anhydride-modified chicken ovalbumin exhibits potent and broad anti-HIV-1 activity: a potential microbicide for preventing sexual transmission of HIV-1.
Lin Li, Lili He, Suiyi Tan, Xinhua Guo, Hong Lu, Zhi Qi, Chungen Pan, Xiuli An, Shibo Jiang, Shuwen Liu
Index: Antimicrob. Agents Chemother. 54(5) , 1700-11, (2010)
Full Text: HTML
Abstract
Heterosexual transmission is the primary route by which women acquire human immunodeficiency virus (HIV)/AIDS. Thus, development of woman-controlled topical microbicides for prevention of sexual transmission of HIV is urgently needed. Here we report that 3-hydroxyphthalic anhydride-modified chicken ovalbumin (HP-OVA) exhibits potent antiviral activity against a broad spectrum of human immunodeficiency virus type 1 (HIV-1) isolates with different genotypes and biotypes. Its antiviral activity is correlated with the percentages of the chemically modified and unmodified lysines and arginines in OVA. HP-OVA inhibits HIV-1 fusion and entry through multiple mechanisms of action, including (i) blocking gp120 binding to CD4 and (ii) interfering with gp41 six-helix bundle formation. Because of the widespread availability and established safety profile of OVA, HP-OVA has good potential to be developed as an effective, safe, and affordable microbicide for prevention of HIV sexual transmission.
Related Compounds
Related Articles:
2003-06-01
[Antiviral Res. 59(1) , 23-33, (2003)]
2011-06-01
[Nan Fang Yi Ke Da Xue Xue Bao 31(7) , 1175-8, (2011)]
2013-03-01
[J. Antimicrob. Chemother. 68(3) , 573-6, (2013)]
2011-04-15
[J. Acquir. Immune Defic. Syndr. 56(5) , 384-92, (2011)]